Can atherosclerosis regress? The role of the vascular extracellular matrix and the age-related changes of arteries

Gerontology

Volumn 48, Issue 5, 2002, Pages 267-278

  Kunz, J ^a  

^a NONE   (Germany)

Author keywords

Age related changes; Atherosclerosis; Diagnostics; Regression; Vascular extracellular matrix

Indexed keywords

COLLAGEN; MATRIX METALLOPROTEINASE; PROTEOGLYCAN;

ATHEROMA; ATHEROSCLEROSIS; BLOOD VESSEL WALL; DIAGNOSTIC IMAGING; EXTRACELLULAR MATRIX; NUCLEAR MAGNETIC RESONANCE; PATHOLOGY; PRIORITY JOURNAL; PROTEIN ANALYSIS; REMISSION; REVIEW; TOMOGRAPHY;

AGING; ANIMALS; ARTERIOSCLEROSIS; DIET, ATHEROGENIC; DISEASE PROGRESSION; ENDOTHELIUM, VASCULAR; EXTRACELLULAR MATRIX; HUMANS; REGRESSION (PSYCHOLOGY); RISK FACTORS;

EID: 0036061457     PISSN: 0304324X     EISSN: None     Source Type: Journal    
DOI: 10.1159/000065248     Document Type: Review

References (118)

1. Can atherosclerotic lesions regress? Angiographic evidence in humans
2. Can atherosclerotic plaques regress? Anatomic and biochemical evidence from nonhuman animal models
3. Long-term induction and regression of diet-induced atherosclerotic lesions in rhesus monkeys
4. Regression of atherosclerosis. Does it occur and does it have clinical meaning?
5. Regression of atherosclerosis. A review
6. Time trends in the prevalence of atherosclerosis: A population-based autopsy study
7. Coronary heart disease in the first 30 years of the 21st century: Challenges and opportunities
8. Proliferation and the monoclonal origins of atherosclerotic lesions
9. The dynamics of progression of coronary atherosclerosis studied in 168 medically treated patients who underwent coronary angiography three times
10. The impact of atherosclerotic arterial remodeling on percentage of luminal stenosis varies widely within the arterial system. A postmortem study
11. Compensatory enlargement of human atherosclerotic coronary arteries
12. Arterial remodeling and coronary artery disease. The concept of 'dilated' versus 'obstructive' coronary atherosclerosis
13. A definition of initial, fatty streak, and intermediate lesions of atherosclerosis
14. Vascular endothelial growth factor upregulates the expression of matrix metalloproteinases in vascular smooth muscle cells. Role of flt-1
15. Initial lesions of vascular aging disease (arteriosclerosis)
16. The intima. Soil for atherosclerosis and restenosis
17. The extracellular matrix as a cell cycle control element in atherosclerosis and restenosis
18. Endothelin-1 synthesis and endothelin B receptor expression in human coronary artery smooth muscle cells and monocyte-derived macrophages is up-regulated by low density lipoproteins
19. Inhibition of vascular cell growth by X-ray irradiation: Comparison with gamma radiation and mechanism of action
20. Cell cycle in vasculo-proliferative diseases. Potential interventions and routes of delivery
21. A role for rho in smooth muscle phenotypic regulation
22. Evidence for a mono-clonal origin of human atherosclerotic plaques
23. The extracellular matrix and atherosclerosis
24. Mechanical strain-induced extracellular matrix production by human vascular smooth muscle cells: Role of TGF-β (1)
25. Overexpression of the V3 variant of versican alters arterial smooth muscle cell adhesion, migration, and proliferation in vitro
26. Proliferation and the monoclonal origins of atherosclerotic lesions
27. Elevated expression of proteglycans in proliferating vascular smooth muscle cells
28. Interaction of native and modified low-density lipoproteins with extracellular matrix
29. Increased expression of matrix metalloproteinases and matrix degrading activity in vulnerable regions of human atherosclerotic plaques
30. Extracellular matrix and cytokines: A functional unit
31. Response of vascular smooth muscle cell to extracellular matrix degradation
32. Distribution of glycosaminoglycans in the intima of human aortas: Changes in atherosclerosis and diabetes mellitus
33. Collagens in human atherosclerosis. Immunohistochemical analysis using collagen type-specific antibodies
34. Collagens and atherosclerosis
35. Collagen synthesis in atherosclerosis: Too much and not enough
36. Chronic AT(1) blockade stimulates extracellular collagen type I degradation and reverses myocardial fibrosis in spontaneously hypertensive rats
37. Increased expression of 72-kd type IV collagenase (MMP-2) in human aortic atherosclerotic lesions
38. Perlecan inhibits smooth muscle cell adhesion to fibronectin: Role of heparan sulfate
39. Spiraled collagen in the major blood vessels
40. Histologic changes in the normal aging aorta: Implications for dissecting aortic aneurysm
41. Role of the extracellular matrix in age-related modifications of the rat aorta. Ultrastructural, morphometric and enzymatic evaluations
42. Aging of the vascular wall and atherosclerosis
43. Age-related changes in the signaling and function of vascular smooth muscle cells
44. Aging of connective tissue
45. Age-related changes in the tunica media of the vertebral artery: Implications for the assessment of vessels injured by trauma
46. The role of AGEs in aging: Causation or correlation
47. Evidence for an age-related dysfunction in the antiproliferative response to transforming growth factor-β in vascular smooth muscle cells
48. Increased expression of matrix metalloproteinase-2 in the thickened intima of aged rats
49. The intima of human coronary arteries
50. A histometrical analysis of age changes in the human lingual artery
51. Symposium on regression of atherosclerosis
52. A maximum confidence approach for measuring progression and regression of coronary artery disease in clinical trials
53. Atherosclerotic changes of extracoronary arteries are associated with the extent of coronary atherosclerosis
54. Prevalence of carotid atherosclerosis in patients with cerebrovascular occlusive disease
55. The intima media thickness and coronary risk factors
56. Prognostic implications of intima-media thickness and plaques in the carotid and femoral arteries in patients with stable angina pectoris
57. The human high-risk plaque and its detection by magnetic resonance imaging
58. Arterial imaging: Comparison of high-resolution US and MR imaging with histologic correlation
59. Human carotid arteries: Correlation of intravascular US with angiographic and histopathologic findings
60. Relationship between ultrasound texture classification images and histology of atherosclerotic plaque
61. Über rückbildungsvorgänge bei der experimentellen atherosklerose
62. Beobachtungen über abheilung arteriosklerotischer geschwüre der Aorta
63. Does therapeutic intervention achieve slowing of progression or bona fide regression of atherosclerotic lesions?
64. A pathomorphological study on atherosclerotic regression with references between apoptosis and atherosclerotic plaque with central depression in rabbit aorta
65. Dietary cholesterol and atherosclerosis
66. Intake of fatty acids and risk of coronary heart disease in a cohort of Finnish men - The alpha-tocopherol, beta-carotene cancer prevention study
67. Dietary fat intake and the risk of coronary heart disease in women
68. The effect of dietary ω-3 fatty acids on coronary atherosclerosis. A Randomized, double-blind, placebo-controlled trial
69. Effects of changes in fat, fish and fibre intakes on death and myocardial reinfarction. Diet and Rein-farction Trial (DART)
70. Controlled trial of fish oil for regression of human coronary atherosclerosis
71. Regression of atherosclerosis in cholesterol-fed rabbits: Effects of fish oil and verapamil
72. Dietary fish oil. Influence on lesion regression in the porcine model of atherosclerosis
73. B-mode ultrasound assessment of pravastatin treatment effect on carotid and femoral artery walls and its correlations with coronary arteriographic findings: A report of the Regression Growth Evaluation Statin Study (REGRESS)
74. A HMG-CoA reductase inhibitor improved regression of atherosclerosis in the rabbit aorta without affecting serum lipid levels: Possible relevance of up-regulation of endothelial NO synthase mRNA
75. Reverse cholesterol transport and atherosclerosis regression
76. High levels of human apolipoprotein A-I and high density lipoproteins in transgenic mice do not enhance efflux of cholesterol from a depot of injected lipoproteins. Relevance to regression of atherosclerosis?
77. Mechanismen der plaquestabilisierung
78. The retardation of progression, stabilization, and regression of coronary and carotid atherosclerosis by low-density lipoprotein apheresis in patients with familial hypercholesterolemia
79. Effect of aggressive versus conventional lipid lowering on atherosclerosis progression in familial hypercholesterolaemia: A prospective, randomised, double-blind trial
80. Effects of lipid-lowering by simvastatin on human atherosclerotic lesions. A longitudinal study by high-resolution, noninvasive magnetic resonance imaging
81. Prospective study of major dietary patterns and risk of coronary heart disease in men
82. Mediterranean diet, traditional risk factors, and the rate of cardiovascular complications after myocardial infarction. Final report of the Lyon Diet Heart Study
83. Intensive lifestyle changes for reversal of coronary heart disease
84. Exercise and atherogenesis: Where is the missing link?
85. Effects of exercise training on vascular function and myocardial perfusion
86. Exercise therapy for claudication
87. Coronary heart disease: Reducing the risk. The scientific background to primary and secondary prevention of coronary heart disease. A worldwide view
88. Wine and your heart. A Science Advisory for Healthcare Professionals from the Nutrition Committee
89. Seven-year changes in alcohol consumption and subsequent risk of cardiovascular disease in men
90. Alcohol consumption and the risk of type 2 diabetes mellitus: Atherosclerosis risk in communities study
91. Mortality from tobacco in developed countries: Indirect estimation from national vital statistics
92. Mortality from smoking worldwide
93. Effects of long-term cigarette smoking on endothelium-dependent responses in humans
94. Effects of cigarette smoke on nitric oxide synthase expression in the rat lung
95. Die pathologische anatomie der arterien bei hypertonie
96. Chlamydia pneumoniae - Ein vermuteter pathogenetischer faktor der koronararteriensklerose
97. Inflammation, CSE inhibitors and Chlamydia pneumoniae. Inflammation, statins and Chlamydia pneumoniae
98. Antibiotics and risk of subsequent first-time acute myocardial infarction
99. The atherogenetic effects of chlamydia are dependent on serum cholesterol and specific to Chlamydia pneumoniae
100. Link between infection and atherosclerosis. Who are the culprits: Viruses, bacteria, both, or neither?
101. Homocysteinemia as a risk factor for atherosclerosis: A review
102. Intraperitoneal infusion of homocysteine increases intimal hyperplasia in balloon-injured rat carotid arteries
103. RAGE: A multiligand receptor contributing to the cellular response in diabetic vasculopathy and inflammation
104. Genetische faktoren der atherosklerosenentstehung
105. Atherosclerosis
106. The proliferative activity of aortic endothelium and its significance of atherogenesis
107. Shear stress induction of the tissue factor gene
108. Distribution of circumferential stress in ruptured and stable atherosclerotic lesions. A structural analysis with histopathological correlation
109. Natural history of calcium deposits in atherosclerosis progression and regression
110. A definition of advanced types of atherosclerotic lesions and a histological classification of atherosclerosis. A report from the Committee on Vascular Lesions of the Council on Arteriosclerosis
111. Effect of pravastatin (10 mg/day) on progression of coronary atherosclerosis in patients with serum total cholesterol levels from 160 to 220 mg/dl and angiographically documented coronary artery disease
112. Effect of aging on aortic morphology in populations with high and low prevalence of hypertension and atherosclerosis
113. Atherosclerosis and the vascular biology of aging
114. Hematopoietic stem cells differentiate into vascular cells that participate in the pathogenesis of atherosclerosis